Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Angiotensin-converting enzyme and the tumor microenvironment: mechanisms beyond angiogenesis.

Okwan-Duodu D, Landry J, Shen XZ, Diaz R.

Am J Physiol Regul Integr Comp Physiol. 2013 Aug 1;305(3):R205-15. doi: 10.1152/ajpregu.00544.2012. Epub 2013 Jun 5. Review.

2.

The peptide network regulated by angiotensin converting enzyme (ACE) in hematopoiesis.

Shen XZ, Bernstein KE.

Cell Cycle. 2011 May 1;10(9):1363-9. Epub 2011 May 1. Review.

3.
4.

Antifibrotic peptide N-acetyl-Ser-Asp-Lys-Pro (Ac-SDKP): opportunities for angiotensin-converting enzyme inhibitor design.

Douglas RG, Ehlers MR, Sturrock ED.

Clin Exp Pharmacol Physiol. 2013 Aug;40(8):535-41. doi: 10.1111/1440-1681.12062. Review.

PMID:
23351021
5.

Effect of N-acetyl-seryl-aspartyl-lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts.

Rhaleb NE, Peng H, Harding P, Tayeh M, LaPointe MC, Carretero OA.

Hypertension. 2001 Mar;37(3):827-32.

6.

Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline.

Azizi M, Rousseau A, Ezan E, Guyene TT, Michelet S, Grognet JM, Lenfant M, Corvol P, Ménard J.

J Clin Invest. 1996 Feb 1;97(3):839-44.

7.

Molecular recognition and regulation of human angiotensin-I converting enzyme (ACE) activity by natural inhibitory peptides.

Masuyer G, Schwager SL, Sturrock ED, Isaac RE, Acharya KR.

Sci Rep. 2012;2:717. doi: 10.1038/srep00717. Epub 2012 Oct 9.

9.

Angiotensin AT(1) receptor signalling modulates reparative angiogenesis induced by limb ischaemia.

Emanueli C, Salis MB, Stacca T, Pinna A, Gaspa L, Madeddu P.

Br J Pharmacol. 2002 Jan;135(1):87-92. Erratum in: Br J Pharmacol 2002 May 1;136(1):157. Maddeddu Paolo [corrected to Madeddu Paolo].

10.

Angiotensin receptors: a new role in cancer?

Deshayes F, Nahmias C.

Trends Endocrinol Metab. 2005 Sep;16(7):293-9. Review.

PMID:
16061390
11.

Angiotensin I-converting enzyme and metabolism of the haematological peptide N-acetyl-seryl-aspartyl-lysyl-proline.

Azizi M, Junot C, Ezan E, Ménard J.

Clin Exp Pharmacol Physiol. 2001 Dec;28(12):1066-9.

PMID:
11903317
13.

Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.

Arafat HA, Gong Q, Chipitsyna G, Rizvi A, Saa CT, Yeo CJ.

J Am Coll Surg. 2007 May;204(5):996-1005; discussion 1005-6.

PMID:
17481528
14.

Angiotensin II binding to angiotensin I-converting enzyme triggers calcium signaling.

Guimarães PB, Alvarenga ÉC, Siqueira PD, Paredes-Gamero EJ, Sabatini RA, Morais RL, Reis RI, Santos EL, Teixeira LG, Casarini DE, Martin RP, Shimuta SI, Carmona AK, Nakaie CR, Jasiulionis MG, Ferreira AT, Pesquero JL, Oliveira SM, Bader M, Costa-Neto CM, Pesquero JB.

Hypertension. 2011 May;57(5):965-72. doi: 10.1161/HYPERTENSIONAHA.110.167171. Epub 2011 Mar 21.

15.

Rethinking the renin-angiotensin system and its role in cardiovascular regulation.

Pagliaro P, Penna C.

Cardiovasc Drugs Ther. 2005 Jan;19(1):77-87. Review.

PMID:
15883759
16.
17.

Changes in the renin angiotensin system during the development of colorectal cancer liver metastases.

Neo JH, Ager EI, Angus PW, Zhu J, Herath CB, Christophi C.

BMC Cancer. 2010 Apr 10;10:134. doi: 10.1186/1471-2407-10-134.

19.

Signaling by the angiotensin-converting enzyme.

Fleming I.

Circ Res. 2006 Apr 14;98(7):887-96. Review.

20.

The renin angiotensin system in the regulation of angiogenesis.

Heffelfinger SC.

Curr Pharm Des. 2007;13(12):1215-29. Review.

PMID:
17504231
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk